September 02, 2014 6:49 PM ET

Health Care Technology

Company Overview of IMS Health Holdings, Inc.

Company Overview

IMS Health Holdings, Inc. provides information, services, and technology to the healthcare industry worldwide. The company develops healthcare measurement solutions, such as IMS LifeLink program that provides data sourced from longitudinal prescriptions, medical claims, and electronic medical records; IMS NPA Market Dynamics, a national prescription audit program; IMS Xponent Prescribing Dynamics, a solution that allows clients to segment and identify physicians, refine messages, adapt and change tactics, and align sales compensation metrics; IMS PlanTrak Market Dynamics, which integrates with patient-level data providing payer and plan level visibility within key performance indicators sepa...

83 Wooster Heights Road

Danbury, CT 06810

United States

Founded in 1954

9,500 Employees

Phone:

203-448-4600

Key Executives for IMS Health Holdings, Inc.

Chairman
Age: 53
Total Annual Compensation: $1.4M
Chief Financial Officer and Senior Vice President
Age: 53
Total Annual Compensation: $412.5K
Senior Vice President of Supply Management
Age: 53
Total Annual Compensation: $402.0K
Senior Vice President of Strategy & Global Pharma Solutions
Age: 49
Total Annual Compensation: $400.3K
Senior Vice President of Global Technology & Operations
Age: 50
Total Annual Compensation: $391.9K
Compensation as of Fiscal Year 2013.

IMS Health Holdings, Inc. Key Developments

IMS Health Holdings, Inc. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended June 30, 2014; Reaffirms Earnings Guidance for the Full Year 2014

IMS Health Holdings, Inc. reported unaudited earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported revenue of $662 million against $624 million a year ago. Operating loss was $39 million against operating income of $97 million a year ago. Loss before income taxes was $359 million against income before income taxes of $17 million a year ago. The second quarter 2014 net loss was $220 million, compared with net income of $8 million in last year's second quarter. The decline was due to several one-time charges relating to the company's IPO, including expenses of $219 million associated with the early termination and refinancing of debt, a $72 million payment to terminate the company's sponsor management services agreement, and a $30 million payment for the extinguishment of non-executive phantom stock grants that vested due to the IPO. Basic and diluted loss per share attributable to common shareholders was $0.67 against basic and diluted earnings per share attributable to common shareholders of $0.03 a year ago. Adjusted net income was $134 million, up 39.8% from $96 million in the prior year's quarter, due to the $20 million increase in adjusted EBITDA and a $25 million reduction in interest expense. Adjusted diluted earnings per share was $0.39 compared with $0.33 in the prior year period. Net cash used in operating activities was $126 million against net cash generated provided by operating activities of $126 million a year ago. Capital expenditures were $12 million against $10 million a year ago. Additions to computer software were $23 million against $18 million a year ago. Free cash outflow was $161 million against free cash inflow $98 million a year ago. For the six months, the company reported revenue of $1,307 million against $1,237 million a year ago. Operating income was $28 million against $176 million a year ago. Loss before income taxes was $396 million against income before income taxes of $34 million a year ago. Net loss was $244 million against net income of $20 million a year ago. Basic and diluted loss per share attributable to common shareholders was $0.80 against basic and diluted earnings per share attributable to common shareholders of $0.07 a year ago. Net debt declined $568 million due to the use of IPO proceeds and cash to reset the capital structure. Net cash used in operating activities was $229 million against net cash generated provided by operating activities of $124 million a year ago. Capital expenditures were $45 million against $17 million a year ago. Additions to computer software were $44 million against $17 million a year ago. Free cash outflow was $318 million against free cash inflow $76 million a year ago. For the full-year 2014, the company reaffirmed guidance for revenue growth of 5% to 6% and adjusted EBITDA growth of 7.5% to 9%. Adjusted Net Income is projected to grow 15% to 20%.

IMS Health Holdings, Inc. to Report Q2, 2014 Results on Jul 24, 2014

IMS Health Holdings, Inc. announced that they will report Q2, 2014 results at 9:00 AM, Eastern Standard Time on Jul 24, 2014

IMS Health Holdings, Inc., Q2 2014 Earnings Call, Jul 24, 2014

IMS Health Holdings, Inc., Q2 2014 Earnings Call, Jul 24, 2014

Similar Private Companies By Industry

Company Name Region
MDdatacor, Inc. United States
CyberPlus Corporation United States
TheraSim, Inc. United States
DermLink, Inc. United States
4G Biometrics, LLC United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
June 24, 2014
Cegedim SA, Information Solutions and Customer Relationship Management Business
Merger/Acquisition
May 8, 2014
Forcea NV/SA
Merger/Acquisition
January 2, 2014
Nielsen N.V., Consumer Health Business in Certain European Markets
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMS Health Holdings, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.